Ultralight, an AI-native software platform designed for modern medical practices, announced it has raised $9.3 million in seed funding to support clinicians delivering personalized, preventive care.
The round was led by The General Partnership, with participation from Wisdom Ventures, Anthemis, Emerson Collective, and GSBackers. The funding comes as a growing number of physicians move away from traditional healthcare systems toward functional, integrative, and longevity-focused care models.
Ultralight aims to replace fragmented medical software systems with a unified platform built specifically for these emerging practices. Many clinicians today rely on multiple disconnected tools for patient data, workflows, and treatment tracking, creating inefficiencies that limit time spent with patients.
Founded by CEO Sunita Mohanty and CTO Pedro Tabio, the company was inspired by firsthand experiences with gaps in healthcare infrastructure. Mohanty’s personal health journey and Tabio’s background in healthcare technology highlighted the need for a more integrated and intelligent system.
The platform aggregates comprehensive patient data, including medical records, lab results, wearable device inputs, and longitudinal symptom tracking. It also features a clinical intelligence layer powered by a proprietary, clinician-reviewed knowledge base, enabling practitioners to generate personalized insights and treatment strategies.
Since its launch in 2025, Ultralight has been adopted by 75 clinics and more than 1,200 clinicians, growing primarily through word-of-mouth within professional communities. Approximately 60% of customers are replacing legacy systems entirely, signaling strong product-market fit.
The company plans to use the new capital to enhance its clinical intelligence capabilities, expand treatment protocol coverage, and build its first dedicated sales team. It is also preparing to support more complex practice structures, including multi-location clinics and hybrid insurance models.
Ultralight also announced a rebrand from its previous name, Vibrant Practice, and the formation of a clinician advisory board featuring leaders in functional and integrative medicine.
KEY QUOTES:
“Doctors are rediscovering the medicine they went into the field to practice — and then finding out the software doesn’t exist to support it. We built Ultralight to be the system they should have had from day one.”
Sunita Mohanty, CEO, Ultralight
“Personalized medicine is crossing the chasm, driven by clinicians leaving legacy systems to build independent practices and by patients demanding deeper, root-cause care. We believe Ultralight can become the system of record for this shift: a single, AI-native platform that integrates the clinical and operational silos that have held modern care back.”
Phin Barnes, Co-Founder and Managing Partner, The General Partnership
“Ultralight has allowed me to do what I think I do best — and that’s being fully present with my patients.“
Dr. Dannette Kallay
